Use of teriflunomide for treating brain atrophy
作者： Ross Rocklin
DOI:
关键词: Teriflunomide 、 Psychology 、 Physical medicine and rehabilitation 、 Atrophy 、 Multiple sclerosis 、 White matter
摘要: This invention relates to the use of teriflunomide for slowing reduction volume white matter in brain, particularly a patient having multiple sclerosis.
lens.org 参考文章(7)
Friedrich-Johannes Kammerer, Rudolph Schleyerbach, Robert R. Bartlett, Medicament to combat autoimmune diseases ,(1993)
J H Simon, Brain atrophy in multiple sclerosis: what we know and would like to know. Multiple Sclerosis Journal. ,vol. 12, pp. 679- 687 ,(2006) , 10.1177/1352458506070823
P. W. O'Connor, D. Li, M. S. Freedman, A. Bar-Or, G.P.A. Rice, C. Confavreux, D. W. Paty, J. A. Stewart, R. Scheyer, , A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses Neurology. ,vol. 66, pp. 894- 900 ,(2006) , 10.1212/01.WNL.0000203121.04509.31
L. Wang, H. M. Lai, D. S. Yoo, M. L. Gawne-Cain, W. I. McDonald, D. H. Miller, A. J. Thompson, N. A. Losseff, Progressive cerebral atrophy in multiple sclerosis A serial MRI study Brain. ,vol. 119, pp. 2009- 2019 ,(1996) , 10.1093/BRAIN/119.6.2009
Robert A Bermel, Rohit Bakshi, The measurement and clinical relevance of brain atrophy in multiple sclerosis The Lancet Neurology. ,vol. 5, pp. 158- 170 ,(2006) , 10.1016/S1474-4422(06)70349-0
G. Tedeschi, L. Lavorgna, P. Russo, A. Prinster, D. Dinacci, G. Savettieri, A. Quattrone, P. Livrea, C. Messina, A. Reggio, V. Bresciamorra, G. Orefice, M. Paciello, A. Brunetti, G. Coniglio, S. Bonavita, A. Di Costanzo, A. Bellacosa, P. Valentino, M. Quarantelli, F. Patti, G. Salemi, E. Cammarata, I. L. Simone, M. Salvatore, V. Bonavita, B. Alfano, Brain atrophy and lesion load in a large population of patients with multiple sclerosis Neurology. ,vol. 65, pp. 280- 285 ,(2005) , 10.1212/01.WNL.0000168837.87351.1F